Wealth manager Lombard Odier has expanded its ‘PrivilEdge’ fund platform, partnering with Polar Capital to launch the PrivilEdge – Polar Capital Global Healthcare fund.
The fund has a high conviction approach, targeting 75-90 healthcare leaders and biotech firms, aiming to achieve a volatility below the MSCI World Healthcare index.
Gareth Powell, head of healthcare at Polar Capital, will be lead manager on the PrivilEdge – Polar Capital Global Healthcare fund. Since 2004, Powell has delivered a 679.6% total return to investors, while the average peer posted a 620.2% total return, according to FE fundinfo data.
See also: ACI: Healthcare stocks on the mend
Powell said: “Healthcare remains one of the most compelling areas of structural growth globally, underpinned by innovation, demographic trends and sustained demand for better outcomes.”
This marks the newest addition to Lombard Odier’s platform, which now has over 30 funds and 9.4bn Swiss francs in assets under management.
See also: Lombard Odier IM acquires Dutch equity strategy
Maxime Perrin, head of open architecture at Lombard Odier, said: “We set up PrivilEdge to offer our clients curated access to some of the best external fund investment ideas on the market.
“This new healthcare fund provides clients with an option to invest in a differentiated and dynamic allocation across the healthcare sector.”
Polar Capital’s Powell added he was “delighted to partner with Lombard Odier” on the new fund.
